• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-260V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pancreatitis (4481)
Event Type  Injury  
Event Description
Olympus medical systems corp.(omsc) received a literature titled "addition of mechanical lithotripsy to endoscopic papillary large balloon dilation in patients with difficult common bile duct stones: a retrospective single-center study."     ¿literature summary¿ this retrospective study aimed to compare the treatment outcomes of endoscopic papillary large-balloon dilation (eplbd) with and without mechanical lithotripsy (ml) in removing difficult common bile duct stones.A total of 122 patients were included (n = 44, eplbd + ml and n = 78, eplbd).Compared with the eplbd group, the eplbd + ml group required more endoscopic retrograde cholangiopancreatography (ercp) procedures (¿2) (86% versus 67%) and longer total ercp time after reaching the papilla (78.5 minutes versus 25 minutes).Methods: patients with difficult common bile duct stones treated with eplbd, with or without ml, at the (b)(6) center between (b)(6) 2014 and (b)(6) 2020, were retrospectively evaluated.The rates of cumulative recurrence and complications were compared between the two groups.Results: overall, 122 patients (n = 44, eplbd + ml and n = 78, eplbd) treated by 12 gastroenterologists were included.Patients in the eplbd + ml group were older (85 years versus 81.5 years) and had larger maximum stone diameter (15 mm versus 12.5 mm) than those in the eplbd group.Compared with the eplbd group, the eplbd + ml group required more endoscopic retrograde cholangiopancreatography (ercp) procedures (¿2) (86% versus 67%) and longer total ercp time after reaching the papilla (78.5 minutes versus 25 minutes).Complication rates were not significantly different (9.1% versus 12.8%); however, the cumulative recurrence rates were higher in the eplbd + ml group than in the eplbd group (69.4% versus 23.5% at 4 years).Conclusion: although there were no differences in complication rates, the long-term recurrence rate was higher in the eplbd + ml group than in the eplbd group.This study emphasizes the added burden imposed by performing ml during ercp and suggests that by appropriate case selection, it is possible to treat cases of difficult biliary stones using eplbd without ml.  ¿type of adverse events/number of patients¿ event1: pancreatitis (eplbd + ml group) 3 cases event2: cholangitis (eplbd + ml group) 1 case event3: pancreatitis (eplbd group) 4 cases event4: cholangitis (eplbd group) 6 cases.
 
Manufacturer Narrative
The literature described jf-260v/tjf-260v duodenoscopes, hence olympus selected tjf-260v was selected as representative model this report is related to the following linked patient identifiers.(b)(6).Once the investigation has been completed, a supplemental report will be submitted with the device evaluation results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA   965-8520
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key18743597
MDR Text Key335813368
Report Number9610595-2024-03562
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/20/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTJF-260V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/23/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
MECHANICAL LITHOTRIPTER, BML-V437QR-30, SN-UNK; STONE RETRIEVAL BASKET, FG-V435P SN-UNK; VISIGLIDE 2 GUIDEWIRE G-260-3545A, SN -UNK
Patient Outcome(s) Other;
-
-